[{"id":"a7e65987-5f6c-4e7e-a85e-bdb565899b8f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05901519","created_at":"2023-06-13T17:08:04.132Z","updated_at":"2024-07-02T16:35:15.919Z","phase":"Phase 2","brief_title":"A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma","source_id_and_acronym":"NCT05901519","lead_sponsor":"University of Michigan Rogel Cancer Center","biomarkers":" TNFRSF1A","pipe":"","alterations":" ","tags":["TNFRSF1A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e prednisone"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 02/16/2024","start_date":" 02/16/2024","primary_txt":" Primary completion: 08/01/2026","primary_completion_date":" 08/01/2026","study_txt":" Completion: 08/01/2026","study_completion_date":" 08/01/2026","last_update_posted":"2024-03-07"},{"id":"65af3a39-ef1d-49dc-a8f5-a6e260b5808e","acronym":"PEACE-1","url":"https://clinicaltrials.gov/study/NCT01957436","created_at":"2021-01-18T08:53:11.774Z","updated_at":"2024-07-02T16:35:29.880Z","phase":"Phase 3","brief_title":"A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer","source_id_and_acronym":"NCT01957436 - PEACE-1","lead_sponsor":"UNICANCER","biomarkers":" ALK","pipe":"","alterations":" ","tags":["ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • abiraterone acetate • prednisone • zoledronic acid"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 1173","initiation":"Initiation: 11/13/2013","start_date":" 11/13/2013","primary_txt":" Primary completion: 08/18/2021","primary_completion_date":" 08/18/2021","study_txt":" Completion: 12/01/2032","study_completion_date":" 12/01/2032","last_update_posted":"2023-11-08"},{"id":"94fe4903-a2c9-42e8-862b-770fa6d33088","acronym":"I-HEP","url":"https://clinicaltrials.gov/study/NCT04810156","created_at":"2021-03-22T11:52:24.698Z","updated_at":"2025-02-25T14:02:17.911Z","phase":"Phase 2","brief_title":"Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis","source_id_and_acronym":"NCT04810156 - I-HEP","lead_sponsor":"Inge Marie Svane","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e prednisone • methylprednisolone sodium succinate • prednisolone"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 04/07/2021","start_date":" 04/07/2021","primary_txt":" Primary completion: 04/07/2025","primary_completion_date":" 04/07/2025","study_txt":" Completion: 11/07/2025","study_completion_date":" 11/07/2025","last_update_posted":"2022-12-14"},{"id":"74b3ecbf-9728-4d5a-931f-2e42f941235f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04588857","created_at":"2021-01-18T21:53:18.276Z","updated_at":"2024-07-02T16:36:14.950Z","phase":"Phase 4","brief_title":"Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia","source_id_and_acronym":"NCT04588857","lead_sponsor":"Rigshospitalet, Denmark","biomarkers":" CRP","pipe":"","alterations":" ","tags":["CRP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dexamethasone injection"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 03/01/2021","start_date":" 03/01/2021","primary_txt":" Primary completion: 12/01/2022","primary_completion_date":" 12/01/2022","study_txt":" Completion: 06/01/2023","study_completion_date":" 06/01/2023","last_update_posted":"2022-03-22"},{"id":"935757e6-fc4c-43e2-b81d-6a4188538dfc","acronym":"","url":"https://clinicaltrials.gov/study/NCT01842321","created_at":"2021-01-18T08:12:38.375Z","updated_at":"2024-07-02T16:36:34.231Z","phase":"Phase 2","brief_title":"Abiraterone Acetate in Molecular Apocrine Breast Cancer","source_id_and_acronym":"NCT01842321","lead_sponsor":"UNICANCER","biomarkers":" HER-2 • ER • PGR • AR","pipe":" | ","alterations":" HER-2 negative • AR positive","tags":["HER-2 • ER • PGR • AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • AR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e abiraterone acetate • prednisone"],"overall_status":"Completed","enrollment":" Enrollment 34","initiation":"Initiation: 07/01/2013","start_date":" 07/01/2013","primary_txt":" Primary completion: 07/15/2015","primary_completion_date":" 07/15/2015","study_txt":" Completion: 07/04/2018","study_completion_date":" 07/04/2018","last_update_posted":"2021-02-23"},{"id":"36cf4d45-d640-4301-9c98-715cbdd5a9d9","acronym":"","url":"https://clinicaltrials.gov/study/NCT01852799","created_at":"2021-01-18T08:16:19.638Z","updated_at":"2024-07-02T16:37:08.000Z","phase":"Phase 2","brief_title":"A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma","source_id_and_acronym":"NCT01852799","lead_sponsor":"Shanghai Changzheng Hospital","biomarkers":" DKK1","pipe":"","alterations":" ","tags":["DKK1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e bortezomib • doxorubicin hydrochloride • dexamethasone injection"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 12/01/2012","start_date":" 12/01/2012","primary_txt":" Primary completion: 09/01/2016","primary_completion_date":" 09/01/2016","study_txt":" Completion: 01/01/2017","study_completion_date":" 01/01/2017","last_update_posted":"2018-08-10"},{"id":"082e8a0d-ed3f-408d-83b4-d1091972e0c2","acronym":"","url":"https://clinicaltrials.gov/study/NCT02815059","created_at":"2021-01-18T13:48:20.869Z","updated_at":"2024-07-02T16:37:14.311Z","phase":"Phase 1","brief_title":"Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone","source_id_and_acronym":"NCT02815059","lead_sponsor":"University of Utah","biomarkers":" ABL1 • BCR","pipe":"","alterations":" ","tags":["ABL1 • BCR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dasatinib • Imbruvica (ibrutinib) • prednisone"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 09/28/2016","start_date":" 09/28/2016","primary_txt":" Primary completion: 01/09/2018","primary_completion_date":" 01/09/2018","study_txt":" Completion: 01/09/2018","study_completion_date":" 01/09/2018","last_update_posted":"2018-01-31"},{"id":"767c3252-70b0-43a5-8f16-55162b11e9d9","acronym":"CABACARE","url":"https://clinicaltrials.gov/study/NCT03356912","created_at":"2021-01-18T16:34:15.578Z","updated_at":"2024-07-02T16:37:15.509Z","phase":"Phase 2","brief_title":"CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy","source_id_and_acronym":"NCT03356912 - CABACARE","lead_sponsor":"Consorzio Oncotech","biomarkers":" AR","pipe":" | ","alterations":" AR splice variant 7","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AR splice variant 7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • abiraterone acetate • prednisone • cabazitaxel"],"overall_status":"Unknown status","enrollment":" Enrollment 220","initiation":"Initiation: 11/22/2017","start_date":" 11/22/2017","primary_txt":" Primary completion: 05/04/2021","primary_completion_date":" 05/04/2021","study_txt":" Completion: 05/04/2021","study_completion_date":" 05/04/2021","last_update_posted":"2017-12-14"},{"id":"97993249-9b0e-4d8d-becd-cd4dbf8ec23d","acronym":"TAXYNERGY","url":"https://clinicaltrials.gov/study/NCT01718353","created_at":"2021-01-18T07:29:43.577Z","updated_at":"2024-07-02T16:37:16.210Z","phase":"Phase 2","brief_title":"Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","source_id_and_acronym":"NCT01718353 - TAXYNERGY","lead_sponsor":"Sanofi","biomarkers":" AR","pipe":"","alterations":" ","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • prednisone • cabazitaxel"],"overall_status":"Completed","enrollment":" Enrollment 63","initiation":"Initiation: 03/01/2013","start_date":" 03/01/2013","primary_txt":" Primary completion: 08/01/2015","primary_completion_date":" 08/01/2015","study_txt":" Completion: 08/01/2015","study_completion_date":" 08/01/2015","last_update_posted":"2017-11-20"},{"id":"1f7a7f14-1d9e-49c2-8bc0-4b64dc4f57f5","acronym":"","url":"https://clinicaltrials.gov/study/NCT02928432","created_at":"2021-01-18T14:23:00.444Z","updated_at":"2024-07-02T16:37:26.171Z","phase":"Phase 2","brief_title":"SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone","source_id_and_acronym":"NCT02928432","lead_sponsor":"Centro Nacional de Investigaciones Oncologicas CARLOS III","biomarkers":" AR","pipe":"","alterations":" ","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e abiraterone acetate • prednisone • dexamethasone"],"overall_status":"Completed","enrollment":" Enrollment 26","initiation":"Initiation: 06/01/2013","start_date":" 06/01/2013","primary_txt":" Primary completion: 09/01/2016","primary_completion_date":" 09/01/2016","study_txt":" Completion: 01/01/2017","study_completion_date":" 01/01/2017","last_update_posted":"2017-01-27"}]